GPR40 Agonist 2 structure
|
Common Name | GPR40 Agonist 2 | ||
|---|---|---|---|---|
| CAS Number | 1147729-48-3 | Molecular Weight | 366.49 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GPR40 Agonist 2GPR40 Agonist 2 is a GPR40 agonist that can be used in the research of diabetes, extracted from patent WO2009054479A1. |
| Name | GPR40 Agonist 2 |
|---|
| Description | GPR40 Agonist 2 is a GPR40 agonist that can be used in the research of diabetes, extracted from patent WO2009054479A1. |
|---|---|
| Related Catalog | |
| Target |
GPR40[1] |
| In Vitro | GPR40 Agonist 2 is a GPR40 agonist that can be used in the research of diabetes[1]. |
| References |
[1]. SHIMADA, Takashi. SPIRO-RING COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES. WO 2009054479 A1. |
| Molecular Weight | 366.49 |
|---|